Leor Landa
ΒιΆΉΘλΏΪ
Filters
Crestview Partners secondary transaction and formation of continuation fund
We advised Crestview on the nearly $600 million GP-led secondary transaction for two portfolio companies
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Amberjack Capital Partners secondary transaction and formation of continuation fund
This transaction marks the third time we have advised Amberjack on a GP-led secondary transaction and continuation fund formation
GrowthCurve CapitalΒ co-investmentΒ for Duetto Research acquisition
We advised GrowthCurve on the transaction
Lightyear GP-led secondary transaction and formation of continuation fund
We advised Lightyear on the secondary transaction andΒ continuation fund formation
White Deer GP-led secondary transaction and formation of continuation fund
We advised White Deer on the secondary transaction and $240 million continuation fund formation
Rubicon closes approximately $1.18BΒ fundraise for second flagship PE fund
We advised Rubicon on the fundraise
Rialto JV for Signature Bank loan portfolio with FDIC, Blackstone and CPPIB
We advised Rialto Capital on the joint venture
Varagon Capital Partners acquisition by Man Group
We are advising Varagon Capital Partners on the transaction
Morgan Stanley AIP closes $2.5 billion secondaries fund
We advised Morgan Stanley AIP on the transaction